ArticleExperimental and therapeutic medicine2020

MicroRNA-654-3p enhances cisplatin sensitivity by targeting QPRT and inhibiting the PI3K/AKT signaling pathway in ovarian cancer cells.

Yi-Chao Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.